Genetic variation at the TNF locus and the risk of severe sequelae of ocular Chlamydia trachomatis infection in Gambians

Genes Immun. 2007 Jun;8(4):288-95. doi: 10.1038/sj.gene.6364384. Epub 2007 Mar 1.


Tumor necrosis factor (TNF) is thought to be a key mediator of the inflammatory and fibrotic response to Chlamydia trachomatis (Ct) infection. A large matched-pair case-control study investigated putative functional single nucleotide polymorphisms (SNPs) across the major histocompatibility complex (MHC) class III region, including TNF and its immediate neighbors nuclear factor of kappa light polypeptide gene enhancer in B cells (IkappaBL), inhibitor like 1 and lymphotoxin alpha (LTA) in relation to the risk of scarring sequelae of ocular Ct infection. Haplotype and linkage disequilibrium analysis demonstrated two haplotypes, differing at position TNF-308, conferring an increased risk of trichiasis. The TNF-308A allele, and its bearing haplotype, correlated with increased TNF production in lymphocyte cultures stimulated with chlamydial elementary body antigen. Thus TNF-308A may determine directly, or be a marker of a high TNF producer phenotype associated with increased risk of sequelae of chlamydial infection. Multivariate analysis provided evidence for the presence of additional risk-associated variants near the TNF locus.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Case-Control Studies
  • Cells, Cultured
  • Child
  • Child, Preschool
  • Chlamydia trachomatis / immunology
  • Disease Progression
  • Female
  • Gambia
  • Genetic Predisposition to Disease
  • Genetic Variation
  • Haplotypes*
  • Humans
  • Male
  • Middle Aged
  • Polymorphism, Single Nucleotide*
  • Trachoma / genetics*
  • Trachoma / immunology
  • Trachoma / physiopathology
  • Tumor Necrosis Factors / blood
  • Tumor Necrosis Factors / genetics*
  • Tumor Necrosis Factors / immunology


  • Tumor Necrosis Factors